The factors relevant to partial remission in children with type 1 diabetes mellitus after measles vaccination: A retrospective study

被引:4
作者
Bektas, Gonca [1 ]
Onal, Hasan [2 ]
Adal, Erdal [3 ]
机构
[1] Bakirkoy Dr Sadi Konuk Res & Training Hosp, Dept Pediat, TR-34147 Istanbul, Turkey
[2] Kanuni Sultan Suleyman Training & Res Hosp, Dept Pediat Metab Dis, Istanbul, Turkey
[3] Istanbul Medipol Univ, Dept Pediat Endocrinol & Metab, Istanbul, Turkey
关键词
immune system; immunomodulation; measles virus; BETA-CELL FUNCTION; DOSE-ADJUSTED HBA1C; ADOLESCENTS; DEFINITION; ONSET; KETOACIDOSIS; PERIOD; YOUNG; RISK;
D O I
10.1002/jmv.25734
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We aimed to identify the determinants of partial remission in patients with type 1 diabetes mellitus (DM), and whether there is an influence of vaccination against measles on partial remission. This was a retrospective study consisting of consecutive patients diagnosed with type 1 DM followed-up from 1 September 2010, through 30 November 2011. The study included children vaccinated within 3 months after diagnosis, and children unvaccinated during the first 12 months of the disease. The daily insulin dose, hemoglobin A1c, and C-peptide levels, and whether children are in partial remission based on the insulin dose-adjusted HbA1c were recorded at diagnosis and 3, 6, 9, 12, 24, and 36 months. A total of 55 children with type 1 DM were analyzed. Thirty-one patients (56.4%) reached partial remission during the follow-up period, whereas 24 of them did not. Patients with diabetic ketoacidosis (DKA) at diagnosis were less likely to reach partial remission than patients without DKA (odds ratio [OR], 0.24; 95% confidence interval [CI], 0.062-0.946;P = .038). Patients vaccinated against measles were more likely to be in partial remission than patients unvaccinated (OR, 4.2; 95% CI, 1.35-13;P = .011). Partial remission was significantly associated with the C-peptide level and insulin dosage at diagnosisP = .002;P = .013, respectively). The lack of DKA, higher C-peptide level, and lower insulin dosage at diagnosis, and vaccination against measles after diagnosis may have an influence on partial clinical remission in patients with new-onset type 1 DM.
引用
收藏
页码:2955 / 2960
页数:6
相关论文
共 29 条
[1]   β-Cell Mass and Type 1 Diabetes Going, Going, Gone? [J].
Akirav, Eitan ;
Kushner, Jake A. ;
Herold, Kevan C. .
DIABETES, 2008, 57 (11) :2883-2888
[2]   Association of interferon-γ and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes [J].
Alizadeh, B. Z. ;
Hanifi-Moghaddam, P. ;
Eerligh, P. ;
van der Slik, A. R. ;
Kolb, H. ;
Kharagjitsingh, A. V. ;
Arias, A. M. Pereira ;
Ronkainen, M. ;
Knip, M. ;
Bonfanti, R. ;
Bonifacio, E. ;
Devendra, D. ;
Wilkin, T. ;
Giphart, M. J. ;
Koeleman, B. P. C. ;
Nolsoe, R. ;
Poulsen, T. Mandrup ;
Schloot, N. C. ;
Roep, B. O. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 145 (03) :480-484
[3]   Partial Remission Definition: Validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish Children with New-Onset Type 1 Diabetes [J].
Andersen, Marie Louise C. Max ;
Hougaard, Philip ;
Porksen, Sven ;
Nielsen, Lotte B. ;
Fredheim, Siri ;
Svensson, Jannet ;
Thomsen, Jane ;
Vikre-Jorgensen, Jennifer ;
Hertel, Thomas ;
Petersen, Jacob S. ;
Hansen, Lars ;
Mortensen, Henrik B. .
PEDIATRIC DIABETES, 2014, 15 (07) :469-476
[4]  
[Anonymous], 2018, VIRAL IMMUNOL, DOI DOI 10.1089/VIM.2017.0143
[5]   Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes [J].
Arif, Sefina ;
Leete, Pia ;
Nguyen, Vy ;
Marks, Katherine ;
Nor, Nurhanani Mohamed ;
Estorninho, Megan ;
Kronenberg-Versteeg, Deborah ;
Bingley, Polly J. ;
Todd, John A. ;
Guy, Catherine ;
Dunger, David B. ;
Powrie, Jake ;
Willcox, Abby ;
Foulis, Alan K. ;
Richardson, Sarah J. ;
de Rinaldis, Emanuele ;
Morgan, Noel G. ;
Lorenc, Anna ;
Peakman, Mark .
DIABETES, 2014, 63 (11) :3835-3845
[6]   Young children (<5 yr) and adolescents (>12 yr) with type 1 diabetes mellitus have low rate of partial remission:: diabetic ketoacidosis is an important risk factor [J].
Bowden, Sasigarn A. ;
Duck, Mary M. ;
Hoffman, Robert P. .
PEDIATRIC DIABETES, 2008, 9 (03) :197-201
[7]   Phases of type 1 diabetes in children and adolescents [J].
Couper, Jennifer J. ;
Haller, Michael J. ;
Ziegler, Annette-G ;
Knip, Mikael ;
Ludvigsson, Johnny ;
Craig, Maria E. .
PEDIATRIC DIABETES, 2014, 15 :18-25
[8]   Definition, epidemiology, and classification of diabetes in children and adolescents [J].
Craig, Maria E. ;
Jefferies, Craig ;
Dabelea, Dana ;
Balde, Naby ;
Seth, Anju ;
Donaghue, Kim C. .
PEDIATRIC DIABETES, 2014, 15 :4-17
[9]   Shorter remission period in young versus older children with diabetes mellitus type 1 [J].
Dost, A. ;
Herbst, A. ;
Kintzel, K. ;
Haberland, H. ;
Roth, C. L. ;
Gortner, L. ;
Holl, R. W. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 (01) :33-37
[10]  
Haralambieva IH, 2013, EXPERT REV VACCINES, V12, P57, DOI [10.1586/erv.12.134, 10.1586/ERV.12.134]